Invivyd (IVVD) Payables (2020 - 2025)
Invivyd (IVVD) reported Payables of $13.7 million for Q4 2025, up 31.55% on a YoY basis from $10.4 million in Q4 2024, and down 24.08% quarter-over-quarter from $18.1 million in Q3 2025.
Invivyd (IVVD) Payables (2020 - 2025) Analysis & Trends
Invivyd has reported Payables for 6 years, with the latest figure at $13.7 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 31.55% year-over-year to $13.7 million; the trailing twelve-month figure through Dec 2025 stood at $13.7 million (up 31.55% YoY), and the FY2025 full-year result was $13.7 million, up 31.55% from the prior year.
- Payables for Q4 2025 stood at $13.7 million, down from $18.1 million in the prior quarter.
- The five-year high for Payables was $18.7 million in Q1 2022, with the low at $1.2 million in Q1 2024.
- Historically, Payables has averaged $10.9 million across 5 years, with a median of $10.4 million in 2024.
- Annual changes were most pronounced in 2024 — Payables plunged 80.25% — and 2025, when it jumped 648.2%.
- Invivyd's Payables stood at $5.8 million in 2021, then sank by 73.77% to $1.5 million in 2022, then soared by 424.26% to $8.0 million in 2023, then jumped by 31.37% to $10.4 million in 2024, then soared by 31.55% to $13.7 million in 2025.
- The last three Payables figures came in at $13.7 million (Q4 2025), $18.1 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 13.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.74 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Jun 30, 2025 | 18.05 Mn |
| Mar 31, 2025 | 8.74 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 16.77 Mn |
| Jun 30, 2022 | 14.23 Mn |
| Mar 31, 2022 | 18.68 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 17.56 Mn |
| Jun 30, 2021 | 10.72 Mn |
| Dec 31, 2020 | 8.15 Mn |